摘要
目的:研究对稳定期慢性阻塞性肺疾病(COPD)患者使用布地奈德福莫特罗联合噻托溴铵进行治疗的临床效果。方法:从常熟市中医院2018年10月至2019年10月收治的稳定期COPD患者中抽选92例患者作为研究对象。采用抽签法将其分为分析组与参照组(46例/组)。为参照组患者采用布地奈德福莫特罗进行治疗,为分析组患者采用布地奈德福莫特罗联合噻托溴铵进行治疗。然后对比两组患者的临床疗效。结果:分析组患者治疗的总有效率(97.83%)高于参照组患者治疗的总有效率(86.96%),P<0.05。结论:对稳定期COPD患者使用布地奈德福莫特罗联合噻托溴铵进行治疗的效果较好。
Objective:To investigate the clinical effect of budesonidoterol combined with tiotropium in patients with stable chronic obstructive pulmonary disease(COPD).Methods:92 patients with stable COPD admitted to Changshu Hospital of Traditional Chinese Medicine from October 2018 to October 2019 were selected as study subjects.They were divided into analysis group and reference group(46 cases/group)by lottery.Patients in the control group were treated with budesonide formoterol,and patients in the analysis group were treated with budesonide formoterol combined with tiotropium bromide.Then the clinical efficacy of the two groups was compared.Results:The total effective rate of patients in the analysis group(97.83%)was higher than that in the control group(86.96%),P<0.05.Conclusion:Budesonide formoterol combined with tiotropium bromide is effective in stable COPD patients.
作者
徐一辛
Xu yi xin(New District Hospital of Changshu Traditional Chinese Medicine Hospital,Changshu 215500)
